You are here
home › news & media
NEWS & MEDIA
Clinical trial to test benefits of fibre supplement to enhance flu vaccine
> Read More
NEWS & MEDIA
VACCINE PATCH TRIAL SUCCESS
Vaxxas’ micro-needle patch demonstrated significantly enhanced immune response compared to vaccination by needle/syringe.
> Read More
NEWS & MEDIA
Scientists have discovered a possible link between Parkinson’s disease and a gene impacted by a neurotoxin found in blue-green algae.
> Read More
NEWS & MEDIA
NEWS & MEDIA
NEW DRUG COMBINATION COULD SUPPORT BETTER CANCER TREATMENTS
Researchers have identified a promising new drug combination that could significantly help the immune system target cancer cells and kill them.
> Read More
NEWS & MEDIA
TRI CEO CALLS FOR EUREKA AWARD NOMINATIONS
Applications for the 2020 Australian Museum Eureka Prizes open this Wednesday!
> Read More
NEWS & MEDIA
World-first human trial into throat cancer associated with Human Papillomavirus using a completely new treatment approach
> Read More
NEWS & MEDIA
Researchers find new details about how joint inflammation evolves in rheumatoid arthritis, and the cells that prolong the inflammatory attack.
> Read More
NEWS & MEDIA
1.5 MILLION FUNDING FOR AGEING AND AGED CARE RESEARCH
The Australian Government awarded $1.5 million funding to Prof Ruth Hubbard for ageing and aged care research
> Read More
NEWS & MEDIA
PROFESSOR RUTH HUBBARD RECEIVES $1.5 MILLION IN RESEARCH FUNDING
Prof Hubbard from UQ Faculty of Medicine and her team who will be leading this project right here at TRI.
> Read More
NEWS & MEDIA
SPARQ-ED IS BACK
SPARQ-ed is seeking expressions of interest from researchers in the building who would like to inspire students to consider STEM subjects and careers
> Read More
NEWS & MEDIA
NEW CEO FOR THE TRANSLATIONAL RESEARCH INSTITUTE
The Translational Research Institute (TRI) Board has appointed renowned respiratory specialist, Professor Scott Bell as the Institute’s new CEO.
> Read More
NEWS & MEDIA
NEWS & MEDIA
2019 EVENTS WRAP UP
Take a look at a snapshot of the events held at TRI through out 2019.
> Read More
NEWS & MEDIA
The drug, pindolol, could be beneficial in treating alcohol use disorders.
> Read More
NEWS & MEDIA
A new treatment for obesity-related liver diseases is being developed by a new UQ spin-off company.
> Read More
NEWS & MEDIA
NEWS & MEDIA
Researchers have discovered a new mechanism used by Epstein-Barr virus, which can cause blood cancers, to evade the immune system.
> Read More
NEWS & MEDIA
METRO SOUTH HEALTH REWARD, RECOGNITION AND RESEARCH EXCELLENCE AWARDS (RRREA)
Almost 50 awards were presented on the evening totalling over $3 million in additional funding
> Read More
NEWS & MEDIA
2020 ROOM BOOKINGS CALENDAR
The TRI 2020 room booking calendar will open at 10am on Monday the 18th of November 2019.
> Read More
NEWS & MEDIA
DR FELICITY DAVIS WINS 2019 METCALF PRIZES FOR STEM CELL RESEARCH
Winners of the National Stem Cell Foundation of Australia’s Metcalf Prizes announced
> Read More
NEWS & MEDIA
AUSTRALIAN CENTRE FOR COMPLEX INTEGRATED SURGICAL SOLUTIONS (ACCISS) LAUNCH
ACCISS offers hope that difficult clinical problems can be solved.
> Read More
NEWS & MEDIA
HEALTH ALERT OVER EIGHT NEW MEASLES CASES REPORTED IN BRISBANE
Eight new cases of measles were reported in Brisbane’s southside area including the PA Hospital
> Read More
- 1 of 14
- older >
© Translational Research Institute Australia
ABN 58 155 991 662
The Translational Research Institute is a medical research facility bringing together The University of Queensland, Metro South Health, Queensland Institute of Technology and Mater Medical Research to translate research findings into improved healthcare and increased income and jobs for Australia. The Translational Research Institute is supported by a grant from the Australian Government.